(Q38939084)

7 September 2017

title

Sequential treatment with aurora B inhibitors enhances cisplatin-mediated apoptosis via c-Myc (English)

1 reference

7 September 2017

Yaxi Ma

1

1 reference

7 September 2017

Handi Cao

2

1 reference

7 September 2017

Siyue Lou

3

1 reference

7 September 2017

Xuejing Shao

4

1 reference

7 September 2017

Wen Lv

5

1 reference

7 September 2017

Xiaotian Qi

6

1 reference

7 September 2017

Yujia Liu

7

1 reference

7 September 2017

Meidan Ying

8

1 reference

7 September 2017

Qiaojun He

9

1 reference

7 September 2017

Xiaochun Yang

10

1 reference

7 September 2017

publication date

21 November 2014

1 reference

Journal of Molecular Medicine

7 September 2017

published in

1 reference

7 September 2017

volume

93

1 reference

7 September 2017

issue

4

1 reference

7 September 2017

page(s)

427-438

1 reference

Epidemiological and molecular aspects of ovarian cancer risk

7 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1228-0

Ovarian cancer: strategies for overcoming resistance to chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1228-0

Aurora kinases A and B are up-regulated by Myc and are essential for maintenance of the malignant state.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1228-0

ZM447439, the Aurora kinase B inhibitor, suppresses the growth of cervical cancer SiHa cells and enhances the chemosensitivity to cisplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1228-0

Aurora-B expression and its correlation with cell proliferation and metastasis in oral cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1228-0

Overexpression of Aurora B is associated with poor prognosis in epithelial ovarian cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1228-0

Aurora kinases as anticancer drug targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1228-0

AZD1152, a selective inhibitor of Aurora B kinase, inhibits human tumor xenograft growth by inducing apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1228-0

Aurora kinase inhibitor AZD1152 has an additional effect of platinum on a sequential application at the human ovarian cancer cell line SKOV3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1228-0

Discovery, synthesis, and in vivo activity of a new class of pyrazoloquinazolines as selective inhibitors of aurora B kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1228-0

Antineoplastic effects of an Aurora B kinase inhibitor in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1228-0

Analysis of Aurora B kinase in non-Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1228-0

Involvement of mitogen-activated protein kinase in signal transducer and activator of transcription-1 mediated differentiation induced by bortezomib in acute myeloid leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1228-0

Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1228-0

Activity of vincristine, L-ASP, and dexamethasone against acute lymphoblastic leukemia is enhanced by the BH3-mimetic ABT-737 in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1228-0

Mechanisms of action of DNA-damaging anticancer drugs in treatment of carcinomas: is acute apoptosis an "off-target" effect?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1228-0

Evaluating cell lines as tumour models by comparison of genomic profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1228-0

Translocations involving c-myc and c-myc function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1228-0

Isoform-specific phosphorylation of human linker histone H1.4 in mitosis by the kinase Aurora B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1228-0

The schedule-dependent enhanced cytotoxic activity of 7-ethyl-10-hydroxy-camptothecin (SN-38) in combination with Gefitinib (Iressa, ZD1839).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1228-0

Aurora B couples chromosome alignment with anaphase by targeting BubR1, Mad2, and Cenp-E to kinetochores

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1228-0

The topoisomerase I poison CPT-11 enhances the effect of the aurora B kinase inhibitor AZD1152 both in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1228-0

Limiting the proliferation of polyploid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1228-0

Intrinsic differences in cisplatin sensitivity of head and neck cancer cell lines: Correlation to lysosomal pH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1228-0

Mitotic arrest, apoptosis, and sensitization to chemotherapy of melanomas by methionine deprivation stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1228-0

Prognostic relevance of c-MYC gene amplification and polysomy for chromosome 8 in suboptimally-resected, advanced stage epithelial ovarian cancers: a Gynecologic Oncology Group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1228-0

Azidothymidine and cisplatin increase p14ARF expression in OVCAR-3 ovarian cancer cell line.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1228-0

The Aurora kinase family in cell division and cancer.

21 January 2018

1 reference

12 December 2020

The c-myc oncogene in tumor progression.

1 reference

12 December 2020

Favorable prognosis of hyperdiploid common acute lymphoblastic leukemia may be explained by sensitivity to antimetabolites and other drugs: results of an in vitro study.

1 reference

12 December 2020

Hypersensitivity to aurora kinase inhibitors in cells resistant against platinum- containing anticancer agents

1 reference

12 December 2020

Aurora-B protein expression is linked to initial response to taxane-based first-line chemotherapy in stage III ovarian carcinoma

1 reference

12 December 2020

Effect of aurora kinase B inhibitor AZD1152 in the treatment of cisplatin-resistant ovarian carcinoma

1 reference

12 December 2020

Cyclosporin A suppresses cisplatin-induced c-fos gene expression in ovarian carcinoma cells

1 reference

12 December 2020

10.1007/S00109-014-1228-0

Identifiers

DOI

1 reference

Dimensions Publication ID

7 September 2017

1018695091

0 references

1 reference